Dexcom Inc. buy melinda
Start price
28.09.17
/
50%
€11.21
Target price
13.11.17
€16.50
Performance (%)
15.33%
End price
13.11.17
€12.93
Summary
This prediction ended on 13.11.17 with a price of €12.93. The prediction had a final performance of 15.33%. melinda has a follow-up prediction for Dexcom Inc. where he still thinks Dexcom Inc. is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dexcom Inc. | -8.311% | -8.311% | 10.566% | 47.045% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
According to melinda what are the pros and cons of Dexcom Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Dexcom Inc. diskutieren
DexCom, Inc. ist ein medizinisches Gerät produzierendes Unternehmen, qui in der Gestaltung, Entwicklung und Vermarktung von kontinuierlichen Glukose-Monitoring-Systeme für den ambulanten Einsatz von Menschen mit diabetes.Its Produkten gehören Dexcom G4 PLATINUM-System Dexcom Studio und Mobile Anwendungen.
(Vom Mitglied beendet)
Current prediction by melinda for Dexcom Inc.
Dexcom Inc.
Start price
Target price
Perf. (%)
€82.42
23.10.23
23.10.23
€90.00
23.10.24
23.10.24
43.22%
02.05.24
02.05.24
Could be worthwhile Investment >10% per year
Stopped prediction by melinda for Dexcom Inc.
Dexcom Inc.
Start price
Target price
Perf. (%)
€57.00
11.02.20
11.02.20
€78.75
04.11.21
04.11.21
137.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Dexcom Inc.
Start price
Target price
Perf. (%)
€10.11
28.09.17
28.09.17
€14.88
13.11.17
13.11.17
15.33%
13.11.17
13.11.17
Could be worthwhile Investment >10% per year